window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Neurosciences

  • Clinical Development,Drug Development,FDA,Neurosciences,Pharmaceuticals and therapeutics,Rare Diseases

    Emalex wins US patent for ecopipam ODT as Tourette access program grows

    Emalex has secured a US patent for an orally disintegrating [...]

    April 17, 2026
  • Neurosciences,Research & Development

    Kinesin-2 motor variants shown to control cargo transport in neurons

    Researchers in Japan have identified distinct kinesin-2 motor protein assemblies [...]

    April 11, 2026
  • Central Nervous System,Clinical Development,Drug Delivery & Formulation,Drug Development,Neurosciences,Patient Centricity

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    Emalex Biosciences has secured a US patent for an orally [...]

    April 11, 2026
  • Clinical Development,Clinical Trials,Digital Health,Funding,Mental health,Neurosciences,Pharmaceuticals and therapeutics

    Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy

    Click Therapeutics has secured a $50M Series D investment from [...]

    April 10, 2026
  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    Allucent has appointed new therapeutic strategy leaders across key disease [...]

    April 9, 2026
  • Artificial Intelligence,Clinical studies,Drug discovery,Neurosciences,Pharmaceuticals and therapeutics

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    A study published in Proceedings of the National Academy of [...]

    April 8, 2026
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    SonoNeu has emerged from stealth as part of a $41.3m [...]

    April 7, 2026
  • Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

    AC Immune has amended its collaboration agreement with Eli Lilly [...]

    April 7, 2026
  • Clinical Trials,Neurosciences,Partnerships & Funding,Research & Development

    City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism

    City St George’s, University of London has partnered with Paradigm [...]

    April 7, 2026
  • Central Nervous System,Mental health,Neurosciences,Research & Development

    Strategies to extend ketamine antidepressant effects identified in new study

    Researchers have identified a molecular target that could extend the [...]

    March 31, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top